| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.91B | 90.56B | 92.42B | 90.93B | 93.66B | 86.33B |
| Gross Profit | 20.53B | 20.57B | 20.82B | 20.66B | 15.43B | 16.83B |
| EBITDA | 11.35B | 10.48B | 11.61B | 10.63B | 8.34B | 6.78B |
| Net Income | 3.09B | 3.28B | 3.26B | 2.72B | -2.01B | -1.23B |
Balance Sheet | ||||||
| Total Assets | 134.83B | 138.63B | 132.32B | 134.05B | 131.78B | 145.39B |
| Cash, Cash Equivalents and Short-Term Investments | 10.30B | 10.12B | 13.37B | 12.80B | 10.16B | 10.07B |
| Total Debt | 42.59B | 47.69B | 43.10B | 43.42B | 43.02B | 55.43B |
| Total Liabilities | 72.21B | 75.74B | 70.09B | 73.18B | 76.89B | 88.36B |
| Stockholders Equity | 58.01B | 60.36B | 57.49B | 56.05B | 50.59B | 52.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.08B | 2.19B | 3.19B | 5.50B | 3.71B |
| Operating Cash Flow | 0.00 | 9.39B | 12.50B | 7.36B | 9.29B | 11.86B |
| Investing Cash Flow | 0.00 | -11.88B | -10.15B | -3.85B | 4.09B | -3.60B |
| Financing Cash Flow | 0.00 | -697.00M | -1.76B | -1.23B | -13.43B | -7.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥155.66B | 7.45 | 10.46% | 2.35% | 2.55% | 72.25% | |
76 Outperform | ¥555.39B | 10.92 | 6.90% | 2.71% | 4.41% | 176.65% | |
74 Outperform | ¥79.96B | 12.74 | ― | 6.64% | 2.45% | 1.87% | |
69 Neutral | ¥63.84B | 10.54 | ― | 3.31% | 2.25% | 30.32% | |
65 Neutral | ¥28.79B | 9.05 | ― | 4.32% | -2.01% | 0.13% | |
63 Neutral | ¥102.79B | 12.38 | 7.53% | 3.01% | 5.17% | 20.72% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |